Learn the recommended dosing for EYLEA for Wet AMD, DR, DME, and MEfRVO. Review full EYLEA administration and dosing information here. See Safety Information and full Prescribing Information.

Aflibercept (Eylea) is indicated for the treatment of people with neovascular (wet) age-related macular degeneration, macular edema following retinal vein occlusion, diabetic macular edema, diabetic retinopathy, and retinopathy of prematurity.

Jan 1, 2025 · Eylea injections are a type of medication used to treat certain eye conditions such as wet age-related macular degeneration and diabetic macular edema. Common short-term side effects of Eylea injections may include eye pain, increased pressure inside the eye, and floaters in the field of vision.

EYLEA is an FDA-approved, anti-VEGF, administered intravitreal injection to treat WET AMD, DME, MefRVO, and DR. Look here for more information about EYLEA. See Safety Information and full Prescribing Information.

Mar 12, 2025 · Eylea is used to treat neovascular (wet) age-related macular degeneration (nAMD) and is FDA-approved for several other eye conditions that involve the retina such as: retinopathy of prematurity (ROP). Eylea is given as an injection into the eye every 1 to 2 months by an eye specialist. Eylea gained FDA approval on November 18, 2011.

Discover EYLEA HD. Learn how EYLEA HD can help treat the retinal diseases Wet AMD, DME, and DR. Click for safety info & full PI

EYLEA is designed to block the growth of new blood vessels and decrease the ability of fluid to pass through blood vessels (vascular permeability) in the eye by blocking VEGF-A and placental growth factor (P L GF), two growth factors involved in angiogenesis.

Consider long-lasting EYLEA HD for Diabetic Macular Edema. EYLEA HD was studied in 658 people with Diabetic Macular Edema (491 were assigned to EYLEA HD). People assigned to EYLEA HD every 3 or 4 months (after 3 initial monthly doses) saw 9 and 8 more letters,

EYLEA is an FDA-approved, anti-VEGF, administered intravitreal injection to treat WET AMD, DME, MefRVO, and DR. Look here for more information about EYLEA. See Safety Information and full Prescribing Information.

Oct 10, 2024 · EYLEA is indicated for the treatment of: 1.1 Neovascular (Wet) Age-Related Macular Degeneration (AMD) 1.2 Macular Edema Following Retinal Vein Occlusion (RVO) 1.3 Diabetic Macular Edema ... 2.1 Important Injection Instructions - For ophthalmic intravitreal injection. EYLEA must only be administered by a qualified physician.